Women who used the Depo-Provera birth control shot and were later diagnosed with a meningioma brain tumor rarely follow the ...

Contraception is often used to prevent pregnancies and manage menstrual cycles—which is exactly why Sandra Somarakis, now 61, and Nicole Ryan, 60, chose it for over a decade. Both women opted for ...

Conversations around women’s health and pharmaceutical accountability are becoming far more urgent across the nation as lawsuits tied to the Depo-Provera birth control shot continue to grow. What ...

Pfizer’s battle over the safety label for its birth control injection has finally come to a close. The pharma giant announced that the Food and Drug Administration approved its new safety warning ...

Doctors said the meningiomas could be linked to the woman using the contraceptive injections — which she had been receiving regularly for 21 years, in order to avoid getting monthly periods "I'd take ...

In June 2026, Pfizer and the lawyers representing women who filed lawsuits involving the Depo-Provera birth control shot told a federal court they had reached a global settlement agreement. This is ...

This week, the FDA approved a label change on Depo Provera, requiring its maker, Pfizer, to warn women about links between use of the birth control injection and brain tumors known as meningiomas.

DMPA is available in two injectable forms: an intramuscular injection, marketed under the name Depo Provera, that can only be administered by a provider, and one that is injected just under the skin.

Recent litigation has accelerated nationwide after studies and regulatory developments raised concerns about a possible link between long-term use of the shot and meningioma tumors. Presented by Staff ...